跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

2-Hydroxyquinoline

首页药物2-Hydroxyquinoline

Experimental

Small Molecule

2-Hydroxyquinoline

未知生产厂商

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

技术标识符

化学式: C₉H₇NO
CAS 编号: 59-31-4
UNII ID: 803BHY7QWU

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COMPOSITIONS FOR AND METHODS OF INHIBITING SARS-COV2 INFECTION
EP 4196154 A4申请人: TEXAS SOUTHERN UNIV优先权: 2020
EP
US
WO
4 件公开
9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound
- US 11958827 B1
  申请人: UNIV KING FAISAL优先权: 2023
  US
  3 件公开
- US 11970477 B1
  申请人: UNIV KING FAISAL优先权: 2023
  US
8-HYDROXYQUINOLINE CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF A CORONA VIRUS DISEASE
EP 4255430 C0申请人: UNIV LJUBLJANI优先权: 2020
EP
WO
2 件公开
2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS
EP 4719412 A1申请人: WESTOL LLC优先权: 2023
EP
WO
2 件公开
SCALE-UP PREPARATION METHOD FOR 6-BROMO-4-HYDROXYQUINOLINE
WO 2026051010 A1申请人: SHANGHAI ZAIQI BIO TECH CO LTD优先权: 2024
CN
WO
2 件公开
Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
US 7186839 B2申请人: SYNGENTA LTD优先权: 2000
US
2 件公开
Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one and methods of their preparation and utilization
US 8299092 B2申请人: KREJCI PETR优先权: 2006
US
2 件公开
Lithium metal quinolates and process for preparation thereof as good emitting, interface materials as well as N-type dopent for organic electronic devices
US 9368734 B2申请人: KAMALASANAN MODEEPARAMPIL NARAYANAN优先权: 2011
US
2 件公开
Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase
US 9394254 B2申请人: COLORADO SEMINARY优先权: 2014
US
2 件公开
Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced cristalline polymorph of the anhydrous form, use thereof for the treatment of Alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharmaceutical composition
US 10189811 B2申请人: FACULDADES CATOLICAS ASSOCIACAO SEM FINS LUCRATIVOS MANTENEDORA DA PONTIFICIA UNIV优先权: 2014
US
2 件公开

第 1 / 10 页